Campbell & CO Investment Adviser LLC Roivant Sciences Ltd. Transaction History
Campbell & CO Investment Adviser LLC
- $1.24 Billion
- Q4 2024
A detailed history of Campbell & CO Investment Adviser LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Campbell & CO Investment Adviser LLC holds 78,011 shares of ROIV stock, worth $836,277. This represents 0.07% of its overall portfolio holdings.
Number of Shares
78,011Holding current value
$836,277% of portfolio
0.07%Shares
1 transactions
Others Institutions Holding ROIV
# of Institutions
329Shares Held
505MCall Options Held
573KPut Options Held
739K-
Qvt Financial LP New York, NY65.8MShares$705 Million76.3% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X062.1MShares$665 Million6.45% of portfolio
-
Viking Global Investors LP47.8MShares$513 Million1.91% of portfolio
-
Vanguard Group Inc Valley Forge, PA44.1MShares$473 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$379 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.55B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...